human antithrombin iii

It is an anticoagulant drug used to prevent the risk of blood clot formation (such as deep vein thrombosis or thromboembolism) in people who have an antithrombin deficiency, whether present from birth or acquired later. It is used during surgical procedures or during the postpartum period, often in combination with heparin.

Form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

Manufacturer: INSTITUTO GRIFOLS S.A.

It is used to prevent and treat the formation of blood clots in adults and children aged 6 years and older who suffer from antithrombin deficiency (either congenital or acquired). It is particularly indicated during surgical procedures, pregnancy, childbirth, or in the presence of kidney disease, liver disease, or massive bleeding.

Form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

Manufacturer: BAXALTA INNOVATIONS GMBH

It is used to prevent the formation of blood clots (deep vein thrombosis and thromboembolism) in patients with an antithrombin deficiency, whether congenital or acquired. It may be used in clinical risk situations, such as during surgery or childbirth, often in association with heparin.

Form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

Manufacturer: KEDRION S.P.A.

It is used for the treatment of congenital antithrombin deficiency and for the prevention or management of deep vein thrombosis and thromboembolism in high-risk situations (such as surgery, childbirth, or postpartum), often in association with heparin. It also serves as replacement therapy to normalize coagulation in cases of acquired antithrombin deficiency.

Form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

Manufacturer: OCTAPHARMA (IP) SPRL

It is used for the prevention of deep vein thrombosis and thromboembolism in patients with an antithrombin deficiency (congenital or acquired), especially in high-risk situations such as surgical procedures or during childbirth. It may be used in association with heparin.

Form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

Manufacturer: KEDRION S.P.A.

It is used to prevent an increased risk of blood clot formation (deep vein thrombosis or thromboembolism) in people with antithrombin deficiency, whether congenital or acquired, during surgical procedures or around the time of childbirth.

Form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

Manufacturer: GRIFOLS ITALIA S.P.A.

It is used for people who do not produce a sufficient amount of antithrombin III. It is used to prevent blood clotting disorders (such as deep vein thrombosis or lung problems) and to treat disseminated intravascular coagulation caused by complications such as shock or systemic infections.

Form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

Manufacturer: CSL BEHRING GMBH